Disproportionality analysis on semaglutide and nonarteritic anterior ischemic optic neuropathy in the FDA adverse event reporting system: An emerging pharmacovigilance signal?
Angela Procacci, Elisabetta Poluzzi, Fabrizio De Ponti, Emanuel Raschi
Topics & Concepts
PharmacovigilanceMedicineAdverse Event Reporting SystemAdverse effectOptic neuropathyAnesthesiaInternal medicineOphthalmologyOptic nerveIntraoperative Neuromonitoring and Anesthetic EffectsDrug-Induced Ocular ToxicityAntiplatelet Therapy and Cardiovascular Diseases